Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group.

---

Martínez C., Khvedelidze I., Fekom M., Deau Fischer B., Marouf A., Ghesquières H., ...Daha Fazla

Bone marrow transplantation, 2025 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası:
• Basım Tarihi: 2025
• Doi Numarası: 10.1038/s41409-025-02568-4
• Dergi Adı: Bone marrow transplantation
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
• İstanbul Üniversitesi Adresli: Evet